Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals ...

The utility score that was used in the cost-utility analysis for end-stage renal disease non-hospitalised patients with secondary hyperparathyroidism was selected on the basis of a range of ...

The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical ...

Typically affecting older dogs, new research studies the benefits of paricalcitol, a drug used for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney failure.

is a condition characterized by the overproduction of parathyroid hormone (PTH) due to chronic kidney disease (CKD), vitamin D deficiency, or other underlying conditions that cause an imbalance in ...

Looking for reliable medications to treat 'Hyperparathyroidism'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Hebrew University researchers test paricalcitol for treating CKD in dogs, showing promise against proteinuria. Study ...